72 results
8-K
EX-1.1
ou2k0
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
424B5
4km2stxmpf0ezmzcati0
29 Nov 23
Prospectus supplement for primary offering
4:47pm
424B5
es26b00u1p4
28 Nov 23
Prospectus supplement for primary offering
4:25pm
8-K
rxmcp0gm479giqhy g1
15 Jun 23
Entry into a Material Definitive Agreement
6:37am
8-K
EX-99.1
1o3n6mza5n
7 Nov 22
Verve Therapeutics Provides Regulatory Update on VERVE-101 Investigational New Drug Application and Reports Third Quarter 2022 Financial Results
7:00am